Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-Blind, Active-Controlled, Two-Treatment, Crossover, Multinational, Multicentre Study to Compare Two Pancreatic Enzyme Products in the Treatment of Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis

NCT01641393 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT01641393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01641393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-Blind, Active-Controlled, Two-Treatment, Crossover, Multinational, Multicentre Study to Compare Two Pancreatic Enzyme Products in the Treatment of Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2012
Completion date
February 28, 2014
Enrollment
96 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

exocrine pancreatic insufficiency: cystic fibrosis